Observation outcomes
breathing difficulties, agitation, arrythmia or neuromuscular paralysis
ADVERSE EFFECTS, SECONDARY
After surgery, patients were transferred to the Post-Anesthesia Care Unit (PACU). The primary observation outcome was the incidence of emergency agitation 0 min (T0) arrived at the PACU, and the incidence of EA at 5(T1), 10(T2), 15(T3), 30(T4) minutes after arrival. The secondary outcomes included the VAS scores, the Rikers SAS scores, the consumption of remifentanil, reaction time (from sevoflurane disconnection to recovery of consciousness), extubation time (from sevoflurane disconnection to extubation) and tramodol comsuption. Any adverse effects related to the intravenous infusion of magnesium sulfate, such as arrythmia or neuromuscular paralysis and breathing difficulties, were also documented.